CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Stonehouse Jon P Director | Option exercise 10b5-1 | +305,995 | $3.22 | $985K | 1,629,845 |
| 2026-03-02 | Stonehouse Jon P Director | Returned to the company 10b5-1 | −305,995 | $8.64 | $2.6M | 1,323,850 |
| 2026-03-02 | Stonehouse Jon P Director | Option exercise · Emp. Stock Option (Right to Buy) 10b5-1 | −305,995 | 0 | ||
| 2026-02-27 | Milne Jill C. Director | Grant or award | +528 | $8.75 | $5K | 15,382 |
| 2026-02-27 | Stonehouse Jon P Director | Grant or award 10b5-1 | +421 | $8.75 | $4K | 1,323,850 |
| 2026-02-27 | MILANO VINCENT Director | Grant or award | +848 | $8.75 | $7K | 92,067 |
| 2026-02-27 | Frank Steven Director | Grant or award | +1,285 | $8.75 | $11K | 18,903 |
| 2026-02-27 | McKee Amy E Director | Grant or award | +642 | $8.75 | $6K | 42,432 |
| 2026-01-23 | Milne Jill C. Director | Grant or award | +2,582 | 2,582 | ||
| 2026-01-23 | Milne Jill C. Director | Grant or award | +12,272 | 14,854 | ||
| 2026-01-23 | Milne Jill C. Director | Grant or award · Automatic Stock Option Grant | +26,684 | 26,684 | ||
| 2025-12-22 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −21,773 | $7.65 | $167K | 398,751 |
| 2025-12-22 | Gayer Charles K President and CCO | Option exercise | +14,142 | $3.22 | $46K | 892,492 |
| 2025-12-22 | Gayer Charles K President and CCO | Option exercise | +10,091 | $5.04 | $51K | 902,583 |
| 2025-12-22 | Gayer Charles K President and CCO | Option exercise | +50,000 | $5.51 | $276K | 952,583 |
| 2025-12-22 | Gayer Charles K President and CCO | Option exercise · Emp. Stock Option (Right to Buy) | −14,142 | 0 | ||
| 2025-12-22 | Gayer Charles K President and CCO | Option exercise · Emp. Stock Option (Right to Buy) | −10,091 | 17,409 | ||
| 2025-12-22 | Gayer Charles K President and CCO | Option exercise · Emp. Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2025-12-19 | Stonehouse Jon P Chief Executive Officer | Shares withheld for taxes | −61,793 | $7.41 | $458K | 1,323,429 |
| 2025-12-19 | Barnes Alane P Chief Legal Officer | Shares withheld for taxes 10b5-1 | −16,902 | $7.41 | $125K | 420,524 |
Page 3 of 18 · 357 trades